Stephanie E Chiuve
Overview
Explore the profile of Stephanie E Chiuve including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
14051
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chiuve S, Fife D, Leitz G, Peterson C, Campbell N, Rennig A, et al.
J Cyst Fibros
. 2023 Oct;
22(6):1017-1023.
PMID: 37880023
Background: High daily doses of pancreatic enzyme replacement therapy (PERT) were historically associated with risk of fibrosing colonopathy (FC) in people with cystic fibrosis (pwCF), leading to development of PERT...
2.
Chomistek A, Phiri K, Doherty M, Calderbank J, Chiuve S, McIlroy B, et al.
Drug Saf
. 2023 Mar;
46(5):515.
PMID: 36964331
No abstract available.
3.
Chomistek A, Phiri K, Doherty M, Calderbank J, Chiuve S, McIlroy B, et al.
Drug Saf
. 2023 Jan;
46(2):209-222.
PMID: 36656445
Introduction And Objective: Validation studies of algorithms for pregnancy outcomes based on International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) codes are important for conducting drug safety research using...
4.
Beck D, Winzenborg I, Gao W, Mostafa N, Chiuve S, Owens C, et al.
Br J Clin Pharmacol
. 2022 Jun;
88(12):5257-5268.
PMID: 35695781
Aim: Elagolix, a gonadotropin-releasing hormone receptor antagonist, was recently approved for heavy menstrual bleeding associated with uterine fibroids (UF, Oriahnn) at a dose of 300 mg twice daily (BID) in...
5.
Chiuve S, Huisingh C, Petruski-Ivleva N, Owens C, Kuohung W, Wise L
J Epidemiol Community Health
. 2021 Jul;
76(1):92-99.
PMID: 34301795
Background: Depression and anxiety are prevalent among women with uterine fibroids (UF). The rate of mental health diagnoses in women with UF has not been studied. Methods: Women aged 18-50...
6.
Loughlin A, Chiuve S, Reznor G, Doherty M, Missmer S, Chomistek A, et al.
Pharmacoepidemiol Drug Saf
. 2021 Jul;
30(12):1675-1686.
PMID: 34292640
Background: The prevalence of adenomyosis is underestimated due to lack of a specific diagnostic code and diagnostic delays given most diagnoses occur at hysterectomy. Objectives: To identify women with adenomyosis...
7.
Beck D, Winzenborg I, Gao W, Mostafa N, Noertersheuser P, Chiuve S, et al.
Clin Transl Sci
. 2021 Mar;
14(4):1452-1463.
PMID: 33650259
Decline of bone mineral density (BMD) during menopause is related to increased risk of fractures in postmenopausal women, however, this relationship in premenopausal women has not been established. To quantify...
8.
Chiuve S, Kilpatrick R, D Hornstein M, Petruski-Ivleva N, Wegrzyn L, Dabrowski E, et al.
Pharmacoepidemiol Drug Saf
. 2021 Feb;
30(6):787-796.
PMID: 33611812
Background: Women with endometriosis are prescribed opioids for pain relief but may be vulnerable to chronic opioid use given their comorbidity profile. Methods: A cohort study was conducted in the...
9.
Kwon B, VanDam C, Chiuve S, Choi H, Entler P, Tan P, et al.
JMIR Mhealth Uhealth
. 2020 Dec;
8(12):e21733.
PMID: 33355537
Background: Diet-tracking mobile apps have gained increased interest from both academic and clinical fields. However, quantity-focused diet tracking (eg, calorie counting) can be time-consuming and tedious, leading to unsustained adoption....
10.
Kilpatrick R, Chiuve S, Leslie W, Wegrzyn L, Gao W, Yang H, et al.
JBMR Plus
. 2020 Dec;
4(12):e10401.
PMID: 33354641
Elagolix, a gonadotrophin-releasing hormone antagonist, is used in premenopausal women with endometriosis. There is a risk of bone loss with elagolix, but the long-term effects of BMD loss later in...